Pathogenesis and transmissibility of highly (H7N1) and low (H7N9) pathogenic avian influenza virus infection in red-legged partridge (Alectoris rufa).
(1/65)
(+info)
Analysis of the clinical characteristics and treatment of two patients with avian influenza virus (H7N9).
(2/65)
Avian influenza is one of the most dangerous contagions in poultry worldwide, and avian influenza A viruses are the major pathogens responsible. Outbreaks of H7N9, a strain of the avian influenza A virus H7 subtype, have increasingly been reported in several countries since 2007. This spring, H7N9 broke out in China and has thus far caused 24 cases of infection and 7 deaths. Recently, we treated two patients with H7N9 infection. The infection was characterized by respiratory symptoms, fever, rapid progression, and significant hypoxemia. Laboratory tests showed a low level or decrease in leukocytes, a drop in blood platelets, and an increase in myocardial enzymes and aspartate aminotransferase. Oseltamivir, anti-infective drugs, and immunoglobulin were administered. Supplemental oxygen or non-invasive mechanical ventilation helped to relieve symptoms. This report provides information on the clinical characteristics and treatment of two Chinese patients with H7N9. (+info)
Epidemiology of human infections with avian influenza A(H7N9) virus in China.
(3/65)
(+info)
Synthetic generation of influenza vaccine viruses for rapid response to pandemics.
(4/65)
(+info)
Clinical findings for early human cases of influenza A(H7N9) virus infection, Shanghai, China.
(5/65)
(+info)
Low immunogenicity predicted for emerging avian-origin H7N9: implication for influenza vaccine design.
(6/65)
(+info)
Pathogenicity of the novel A/H7N9 influenza virus in mice.
(7/65)
(+info)
Case-control study of risk factors for human infection with influenza A(H7N9) virus in Jiangsu Province, China, 2013.
(8/65)
(+info)